FREE SHIPPING over $40
OVER 9000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Home / Equine Research Bank / Front Vet Sci / Differential Proteomic Expression of Equine Cardiac and Lame...
Frontiers in veterinary science2020; 7; 308; doi: 10.3389/fvets.2020.00308

Differential Proteomic Expression of Equine Cardiac and Lamellar Tissue During Insulin-Induced Laminitis.

Abstract: Endocrinopathic laminitis is pathologically similar to the multi-organ dysfunction and peripheral neuropathy found in human patients with metabolic syndrome. Similarly, endocrinopathic laminitis has been shown to partially result from vascular dysfunction. However, despite extensive research, the pathogenesis of this disease is not well elucidated and laminitis remains without an effective treatment. Here, we sought to identify novel proteins and pathways underlying the development of equine endocrinopathic laminitis. Healthy Standardbred horses ( = 4/group) were either given an electrolyte infusion, or a 48-h euglycemic-hyperinsulinemic clamp. Cardiac and lamellar tissues were analyzed by mass spectrometry (FDR = 0.05). All hyperinsulinemic horses developed laminitis despite being previously healthy. We identified 514 and 709 unique proteins in the cardiac and lamellar proteomes, respectively. In the lamellar tissue, we identified 14 proteins for which their abundance was significantly increased and 13 proteins which were significantly decreased in the hyperinsulinemic group as compared to controls. These results were confirmed via real-time reverse-transcriptase PCR. A STRING analysis of protein-protein interactions revealed that these increased proteins were primarily involved in coagulation and complement cascades, platelet activity, and ribosomal function, while decreased proteins were involved in focal adhesions, spliceosomes, and cell-cell matrices. Novel significant differentially expressed proteins associated with hyperinsulinemia-induced laminitis include talin-1, vinculin, cadherin-13, fibrinogen, alpha-2-macroglobulin, and heat shock protein 90. In contrast, no proteins were found to be significantly differentially expressed in the heart of hyperinsulinemic horses compared to controls. Together, these data indicate that while hyperinsulinemia induced, in part, microvascular damage, complement activation, and ribosomal dysfunction in the lamellae, a similar effect was not seen in the heart. In brief, this proteomic investigation of a unique equine model of hyperinsulinemia identified novel proteins and signaling pathways, which may lead to the discovery of molecular biomarkers and/or therapeutic targets for endocrinopathic laminitis.
Copyright © 2020 Campolo, Frantz, de Laat, Hartson, Furr and Lacombe.
Get Full Text
Publication Date: 2020-06-12 PubMed ID: 32596266PubMed Central: PMC7303262DOI: 10.3389/fvets.2020.00308Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The researchers conducted a thorough investigation of novel proteins and pathways that may be involved in the development of equine endocrinopathic laminitis, a disease similar to human metabolic syndrome lacking effective treatment. In this study, the researchers subjected Standardbred horses to hyperinsulinemia, triggering laminitis, isolated cardiac and lamellar tissues, and then carried out proteomic analysis.

Research Methodology

  • The researchers used healthy Standardbred horses, dividing them into two groups. One group was given an electrolyte infusion, while the other group was subjected to a 48-hour euglycemic-hyperinsulinemic clamp – a procedure intended to induce hyperinsulinemia and subsequently, laminitis.
  • Upon developing laminitis, cardiac and lamellar tissues were extracted from the horses and were analyzed with mass spectrometry – a technique allowing them to identify and quantify proteins in these tissues.

Results of the Study

  • Indeed, all horses that were made hyperinsulinemic developed laminitis. The researchers identified a total of 514 unique proteins in the cardiac proteomes and 709 in the lamellar proteomes.
  • Specially in the lamellar tissue, they found significant changes in the levels of 27 proteins – 14 increased and 13 decreased – associated with the hyperinsulinemic state.
  • Through a STRING analysis, a method to understand protein-protein interactions, it was found that increased proteins were mainly linked to coagulation and complement cascades, platelet activity, and ribosomal function. On the other hand, the decreased proteins were involved in spliceosomes, focal adhesions, and cell-cell matrices.
  • The new significant proteins associated with hyperinsulinemia-induced laminitis were identified, which include talin-1, vinculin, cadherin-13, fibrinogen, alpha-2-macroglobulin, and heat shock protein 90.
  • Interestingly, no significant protein expression difference was noted in the heart tissues of the hyperinsulinemic horses compared to the control group.

Conclusion and Implications

  • The research underscored the pathological impact of hyperinsulinemia on horse lamellae, leading to microvascular damage, complement activation, and ribosomal dysfunction, while a similar effect was not observed in the heart.
  • These newly identified proteins and signaling pathways in the lamellar tissue under hyperinsulinemia could potentially be employed as molecular biomarkers for early detection or as therapeutic targets for the treatment of endocrinopathic laminitis.

Cite This Article

APA
Campolo A, Frantz MW, de Laat MA, Hartson SD, Furr MO, Lacombe VA. (2020). Differential Proteomic Expression of Equine Cardiac and Lamellar Tissue During Insulin-Induced Laminitis. Front Vet Sci, 7, 308. https://doi.org/10.3389/fvets.2020.00308

Publication

Frontiers in veterinary science
ISSN: 2297-1769
NlmUniqueID: 101666658
Country: Switzerland
Language: English
Volume: 7
Pages: 308
PII: 308

Researcher Affiliations

Campolo, Allison
  • Department of Biochemistry and Molecular Biology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, United States.
Frantz, Matthew W
  • Department of Biochemistry and Molecular Biology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, United States.
de Laat, Melody A
  • Department of Biochemistry and Molecular Biology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, United States.
  • Biosciences, Queensland University of Technology, Brisbane, QLD, Australia.
Hartson, Steven D
  • Department of Biochemistry and Molecular Biology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, United States.
Furr, Martin O
  • Department of Biochemistry and Molecular Biology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, United States.
Lacombe, Véronique A
  • Department of Biochemistry and Molecular Biology, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, OK, United States.

References

This article includes 58 references
  1. Thatcher CD, Pleasant RS, Geor RJ, Elvinger F, Negrin KA, Franklin J. Prevalence of obesity in mature horses: an equine body condition study.. J Anim Physiol Anim Nutr (2008) 92:222.
    doi: 10.1111/j.1439-0396.2007.00789_8.xpubmed: 0google scholar: lookup
  2. Wylie CE, Collins SN, Verheyen KL, Richard Newton J. Frequency of equine laminitis: a systematic review with quality appraisal of published evidence.. Vet J 2011 Sep;189(3):248-56.
    doi: 10.1016/j.tvjl.2011.04.014pubmed: 21665498google scholar: lookup
  3. Morgan RA, Keen JA, Walker BR, Hadoke PW. Vascular Dysfunction in Horses with Endocrinopathic Laminitis.. PLoS One 2016;11(9):e0163815.
    doi: 10.1371/journal.pone.0163815pmc: PMC5042533pubmed: 27684374google scholar: lookup
  4. Roustit M, Loader J, Deusenbery C, Baltzis D, Veves A. Endothelial Dysfunction as a Link Between Cardiovascular Risk Factors and Peripheral Neuropathy in Diabetes.. J Clin Endocrinol Metab 2016 Sep;101(9):3401-8.
    doi: 10.1210/jc.2016-2030pmc: PMC5010566pubmed: 27399351google scholar: lookup
  5. Malik S, Wong ND, Franklin SS, Kamath TV, L'Italien GJ, Pio JR, Williams GR. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.. Circulation 2004 Sep 7;110(10):1245-50.
    doi: 10.1161/01.CIR.0000140677.20606.0Epubmed: 15326067google scholar: lookup
  6. Maria Z, Campolo AR, Lacombe VA. Diabetes Alters the Expression and Translocation of the Insulin-Sensitive Glucose Transporters 4 and 8 in the Atria.. PLoS One 2015;10(12):e0146033.
    doi: 10.1371/journal.pone.0146033pmc: PMC4697822pubmed: 26720696google scholar: lookup
  7. Campolo A, de Laat MA, Keith L, Gruntmeir KJ, Lacombe VA. Prolonged hyperinsulinemia affects metabolic signal transduction markers in a tissue specific manner.. Domest Anim Endocrinol 2016 Apr;55:41-5.
    doi: 10.1016/j.domaniend.2015.11.001pubmed: 26773366google scholar: lookup
  8. Leise BS, Watts MR, Roy S, Yilmaz AS, Alder H, Belknap JK. Use of laser capture microdissection for the assessment of equine lamellar basal epithelial cell signalling in the early stages of laminitis.. Equine Vet J 2015 Jul;47(4):478-88.
    doi: 10.1111/evj.12283pmc: PMC4771185pubmed: 24750316google scholar: lookup
  9. de Laat MA, Gruntmeir KJ, Pollitt CC, McGowan CM, Sillence MN, Lacombe VA. Hyperinsulinemia Down-Regulates TLR4 Expression in the Mammalian Heart.. Front Endocrinol (Lausanne) 2014;5:120.
    doi: 10.3389/fendo.2014.00120pmc: PMC4105691pubmed: 25101057google scholar: lookup
  10. Wang L, Pawlak EA, Johnson PJ, Belknap JK, Eades S, Stack S, Cousin H, Black SJ. Impact of laminitis on the canonical Wnt signaling pathway in basal epithelial cells of the equine digital laminae.. PLoS One 2013;8(2):e56025.
    doi: 10.1371/journal.pone.0056025pmc: PMC3566061pubmed: 23405249google scholar: lookup
  11. de Laat MA, Kyaw-Tanner MT, Nourian AR, McGowan CM, Sillence MN, Pollitt CC. The developmental and acute phases of insulin-induced laminitis involve minimal metalloproteinase activity.. Vet Immunol Immunopathol 2011 Apr 15;140(3-4):275-81.
    doi: 10.1016/j.vetimm.2011.01.013pubmed: 21333362google scholar: lookup
  12. de Laat MA, Robinson MA, Gruntmeir KJ, Liu Y, Soma LR, Lacombe VA. AICAR administration affects glucose metabolism by upregulating the novel glucose transporter, GLUT8, in equine skeletal muscle.. Vet J 2015 Sep;205(3):381-6.
    doi: 10.1016/j.tvjl.2015.05.018pubmed: 26116041google scholar: lookup
  13. Carter RA, Shekk V, de Laat MA, Pollitt CC, Galantino-Homer HL. Novel keratins identified by quantitative proteomic analysis as the major cytoskeletal proteins of equine (Equus caballus) hoof lamellar tissue.. J Anim Sci 2010 Dec;88(12):3843-55.
    doi: 10.2527/jas.2010-2964pubmed: 20622188google scholar: lookup
  14. Steelman SM, Chowdhary BP. Plasma proteomics shows an elevation of the anti-inflammatory protein APOA-IV in chronic equine laminitis.. BMC Vet Res 2012 Sep 27;8:179.
    doi: 10.1186/1746-6148-8-179pmc: PMC3511297pubmed: 23016951google scholar: lookup
  15. de Laat MA, McGowan CM, Sillence MN, Pollitt CC. Equine laminitis: induced by 48 h hyperinsulinaemia in Standardbred horses.. Equine Vet J 2010 Mar;42(2):129-35.
    doi: 10.2746/042516409X475779pubmed: 20156248google scholar: lookup
  16. Voruganti S, Lacroix JC, Rogers CN, Rogers J, Matts RL, Hartson SD. The anticancer drug AUY922 generates a proteomics fingerprint that is highly conserved among structurally diverse Hsp90 inhibitors.. J Proteome Res 2013 Aug 2;12(8):3697-706.
    doi: 10.1021/pr400321xpmc: PMC3784992pubmed: 23763277google scholar: lookup
  17. Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification.. Nat Biotechnol 2008 Dec;26(12):1367-72.
    doi: 10.1038/nbt.1511pubmed: 19029910google scholar: lookup
  18. Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, Mann M, Cox J. The Perseus computational platform for comprehensive analysis of (prote)omics data.. Nat Methods 2016 Sep;13(9):731-40.
    doi: 10.1038/nmeth.3901pubmed: 27348712google scholar: lookup
  19. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing.. J R Stat Soc (1995) 57:289–300.
    doi: 10.1111/j.2517-6161.1995.tb02031.xgoogle scholar: lookup
  20. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method.. Nat Protoc 2008;3(6):1101-8.
    doi: 10.1038/nprot.2008.73pubmed: 18546601google scholar: lookup
  21. Coté N, Trout DR, Hayes AM. Evaluation of plasma alpha-2-macroglobulin and interactions with tumour necrosis factor-alpha in horses with endotoxemic signs.. Can J Vet Res 1996 Apr;60(2):150-7.
    pmc: PMC1263822pubmed: 8785722
  22. Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus M, Lampugnani MG, Martin-Padura I, Stoppacciaro A, Ruco L, McDonald DM, Ward PA, Dejana E. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo.. Proc Natl Acad Sci U S A 1999 Aug 17;96(17):9815-20.
    doi: 10.1073/pnas.96.17.9815pmc: PMC22293pubmed: 10449777google scholar: lookup
  23. Beauvais DM, Rapraeger AC. Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation.. J Cell Sci 2010 Nov 1;123(Pt 21):3796-807.
    doi: 10.1242/jcs.067645pmc: PMC2964108pubmed: 20971705google scholar: lookup
  24. Copas VE, Durham AE, Stratford CH, McGorum BC, Waggett B, Pirie RS. In equine grass sickness, serum amyloid A and fibrinogen are elevated, and can aid differential diagnosis from non-inflammatory causes of colic.. Vet Rec 2013 Apr 13;172(15):395.
    doi: 10.1136/vr.101224pubmed: 23428423google scholar: lookup
  25. von Essen M, Rahikainen R, Oksala N, Raitoharju E, Seppälä I, Mennander A, Sioris T, Kholová I, Klopp N, Illig T, Karhunen PJ, Kähönen M, Lehtimäki T, Hytönen VP. Talin and vinculin are downregulated in atherosclerotic plaque; Tampere Vascular Study.. Atherosclerosis 2016 Dec;255:43-53.
    doi: 10.1016/j.atherosclerosis.2016.10.031pubmed: 27816808google scholar: lookup
  26. Avenatti RC, Mckeever K, Horohov DW, Malinowski K. Effects of age and exercise on inflammatory cytokines, HSP70 and HSP90 gene expression and protein content in Standardbred horses.. Comp Exerc Physiol (2018) 14:27–46.
    doi: 10.3920/CEP170020google scholar: lookup
  27. Zamir E, Geiger B. Molecular complexity and dynamics of cell-matrix adhesions.. J Cell Sci 2001 Oct;114(Pt 20):3583-90.
    pubmed: 11707510doi: 10.1242/jcs.114.20.3583google scholar: lookup
  28. Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD. Complement and coagulation: strangers or partners in crime?. Trends Immunol 2007 Apr;28(4):184-92.
    doi: 10.1016/j.it.2007.02.006pubmed: 17336159google scholar: lookup
  29. Karikoski NP, Horn I, McGowan TW, McGowan CM. The prevalence of endocrinopathic laminitis among horses presented for laminitis at a first-opinion/referral equine hospital.. Domest Anim Endocrinol 2011 Oct;41(3):111-7.
    doi: 10.1016/j.domaniend.2011.05.004pubmed: 21696910google scholar: lookup
  30. Karikoski NP, McGowan CM, Singer ER, Asplin KE, Tulamo RM, Patterson-Kane JC. Pathology of Natural Cases of Equine Endocrinopathic Laminitis Associated With Hyperinsulinemia.. Vet Pathol 2015 Sep;52(5):945-56.
    doi: 10.1177/0300985814549212pubmed: 25232034google scholar: lookup
  31. de Laat MA, Clement CK, McGowan CM, Sillence MN, Pollitt CC, Lacombe VA. Toll-like receptor and pro-inflammatory cytokine expression during prolonged hyperinsulinaemia in horses: implications for laminitis.. Vet Immunol Immunopathol 2014 Jan 15;157(1-2):78-86.
    doi: 10.1016/j.vetimm.2013.10.010pubmed: 24246153google scholar: lookup
  32. Waller AP, Huettner L, Kohler K, Lacombe VA. Novel link between inflammation and impaired glucose transport during equine insulin resistance.. Vet Immunol Immunopathol 2012 Oct 15;149(3-4):208-15.
    doi: 10.1016/j.vetimm.2012.07.003pubmed: 22871576google scholar: lookup
  33. de Laat MA, Clement CK, Sillence MN, McGowan CM, Pollitt CC, Lacombe VA. The impact of prolonged hyperinsulinaemia on glucose transport in equine skeletal muscle and digital lamellae.. Equine Vet J 2015 Jul;47(4):494-501.
    doi: 10.1111/evj.12320pubmed: 24995680google scholar: lookup
  34. Waller AP, Kohler K, Burns TA, Mudge MC, Belknap JK, Lacombe VA. Naturally occurring compensated insulin resistance selectively alters glucose transporters in visceral and subcutaneous adipose tissues without change in AS160 activation.. Biochim Biophys Acta 2011 Sep;1812(9):1098-103.
    doi: 10.1016/j.bbadis.2011.02.007pmc: PMC3143249pubmed: 21352908google scholar: lookup
  35. de Laat MA, Pollitt CC, Kyaw-Tanner MT, McGowan CM, Sillence MN. A potential role for lamellar insulin-like growth factor-1 receptor in the pathogenesis of hyperinsulinaemic laminitis.. Vet J 2013 Aug;197(2):302-6.
    doi: 10.1016/j.tvjl.2012.12.026pubmed: 23394844google scholar: lookup
  36. Das Evcimen N, King GL. The role of protein kinase C activation and the vascular complications of diabetes.. Pharmacol Res 2007 Jun;55(6):498-510.
    doi: 10.1016/j.phrs.2007.04.016pubmed: 17574431google scholar: lookup
  37. Philippova M, Joshi MB, Pfaff D, Kyriakakis E, Maslova K, Erne P, Resink TJ. T-cadherin attenuates insulin-dependent signalling, eNOS activation, and angiogenesis in vascular endothelial cells.. Cardiovasc Res 2012 Mar 1;93(3):498-507.
    doi: 10.1093/cvr/cvs004pubmed: 22235028google scholar: lookup
  38. Chung CM, Lin TH, Chen JW, Leu HB, Yang HC, Ho HY, Ting CT, Sheu SH, Tsai WC, Chen JH, Lin SJ, Chen YT, Pan WH. A genome-wide association study reveals a quantitative trait locus of adiponectin on CDH13 that predicts cardiometabolic outcomes.. Diabetes 2011 Sep;60(9):2417-23.
    doi: 10.2337/db10-1321pmc: PMC3161336pubmed: 21771975google scholar: lookup
  39. Kern PA, Di Gregorio GB, Lu T, Rassouli N, Ranganathan G. Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression.. Diabetes 2003 Jul;52(7):1779-85.
    doi: 10.2337/diabetes.52.7.1779pubmed: 12829646google scholar: lookup
  40. Menzies-Gow NJ, Harris PA, Elliott J. Prospective cohort study evaluating risk factors for the development of pasture-associated laminitis in the United Kingdom.. Equine Vet J 2017 May;49(3):300-306.
    doi: 10.1111/evj.12606pubmed: 27363591google scholar: lookup
  41. Takeuchi T, Adachi Y, Ohtsuki Y, Furihata M. Adiponectin receptors, with special focus on the role of the third receptor, T-cadherin, in vascular disease.. Med Mol Morphol 2007 Sep;40(3):115-20.
    doi: 10.1007/s00795-007-0364-9pubmed: 17874043google scholar: lookup
  42. Frismantiene A, Pfaff D, Frachet A, Coen M, Joshi MB, Maslova K, Bochaton-Piallat ML, Erne P, Resink TJ, Philippova M. Regulation of contractile signaling and matrix remodeling by T-cadherin in vascular smooth muscle cells: constitutive and insulin-dependent effects.. Cell Signal 2014 Sep;26(9):1897-908.
    doi: 10.1016/j.cellsig.2014.05.001pubmed: 24815187google scholar: lookup
  43. Tyrberg B, Miles P, Azizian KT, Denzel MS, Nieves ML, Monosov EZ, Levine F, Ranscht B. T-cadherin (Cdh13) in association with pancreatic β-cell granules contributes to second phase insulin secretion.. Islets 2011 Nov-Dec;3(6):327-37.
    doi: 10.4161/isl.3.6.17705pmc: PMC3329514pubmed: 21975561google scholar: lookup
  44. Takada Y, Takada YK, Fujita M. Crosstalk between insulin-like growth factor (IGF) receptor and integrins through direct integrin binding to IGF1.. Cytokine Growth Factor Rev 2017 Apr;34:67-72.
    doi: 10.1016/j.cytogfr.2017.01.003pmc: PMC5401657pubmed: 28190785google scholar: lookup
  45. Alam N, Goel HL, Zarif MJ, Butterfield JE, Perkins HM, Sansoucy BG, Sawyer TK, Languino LR. The integrin-growth factor receptor duet.. J Cell Physiol 2007 Dec;213(3):649-53.
    doi: 10.1002/jcp.21278pubmed: 17886260google scholar: lookup
  46. Stolla MC, Li D, Lu L, Woulfe DS. Enhanced platelet activity and thrombosis in a murine model of type I diabetes are partially insulin-like growth factor 1-dependent and phosphoinositide 3-kinase-dependent.. J Thromb Haemost 2013 May;11(5):919-29.
    doi: 10.1111/jth.12170pubmed: 23406214google scholar: lookup
  47. Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix.. Int J Biochem Cell Biol 2004 Jun;36(6):1031-7.
    doi: 10.1016/j.biocel.2003.12.003pubmed: 15094118google scholar: lookup
  48. Kannel WB, D'Agostino RB, Wilson PW, Belanger AJ, Gagnon DR. Diabetes, fibrinogen, and risk of cardiovascular disease: the Framingham experience.. Am Heart J 1990 Sep;120(3):672-6.
    doi: 10.1016/0002-8703(90)90026-Tpubmed: 2389702google scholar: lookup
  49. Parsons CS, Orsini JA, Krafty R, Capewell L, Boston R. Risk factors for development of acute laminitis in horses during hospitalization: 73 cases (1997-2004).. J Am Vet Med Assoc 2007 Mar 15;230(6):885-9.
    doi: 10.2460/javma.230.6.885pubmed: 17362165google scholar: lookup
  50. James K, Merriman J, Gray RS, Duncan LJ, Herd R. Serum alpha 2-macroglobulin levels in diabetes.. J Clin Pathol 1980 Feb;33(2):163-6.
    doi: 10.1136/jcp.33.2.163pmc: PMC1146013pubmed: 6154066google scholar: lookup
  51. Carr ME. Diabetes mellitus: a hypercoagulable state.. J Diabetes Complications 2001 Jan-Feb;15(1):44-54.
    doi: 10.1016/S1056-8727(00)00132-Xpubmed: 11259926google scholar: lookup
  52. Kurucz I, Morva A, Vaag A, Eriksson KF, Huang X, Groop L, Koranyi L. Decreased expression of heat shock protein 72 in skeletal muscle of patients with type 2 diabetes correlates with insulin resistance.. Diabetes 2002 Apr;51(4):1102-9.
    doi: 10.2337/diabetes.51.4.1102pubmed: 11916932google scholar: lookup
  53. Venojärvi M, Korkmaz A, Aunola S, Hällsten K, Virtanen K, Marniemi J, Halonen JP, Hänninen O, Nuutila P, Atalay M. Decreased thioredoxin-1 and increased HSP90 expression in skeletal muscle in subjects with type 2 diabetes or impaired glucose tolerance.. Biomed Res Int 2014;2014:386351.
    doi: 10.1155/2014/386351pmc: PMC3932292pubmed: 24689038google scholar: lookup
  54. Lazaro I, Oguiza A, Recio C, Mallavia B, Madrigal-Matute J, Blanco J, Egido J, Martin-Ventura JL, Gomez-Guerrero C. Targeting HSP90 Ameliorates Nephropathy and Atherosclerosis Through Suppression of NF-κB and STAT Signaling Pathways in Diabetic Mice.. Diabetes 2015 Oct;64(10):3600-13.
    doi: 10.2337/db14-1926pubmed: 26116697google scholar: lookup
  55. Lazaro I, Oguiza A, Recio C, Lopez-Sanz L, Bernal S, Egido J, Gomez-Guerrero C. Interplay between HSP90 and Nrf2 pathways in diabetes-associated atherosclerosis.. Clin Investig Arterioscler 2017 Mar-Apr;29(2):51-59.
    doi: 10.1016/j.arteri.2016.10.003pubmed: 28188022google scholar: lookup
  56. Riebold M, Kozany C, Freiburger L, Sattler M, Buchfelder M, Hausch F, Stalla GK, Paez-Pereda M. A C-terminal HSP90 inhibitor restores glucocorticoid sensitivity and relieves a mouse allograft model of Cushing disease.. Nat Med 2015 Mar;21(3):276-80.
    doi: 10.1038/nm.3776pubmed: 25665180google scholar: lookup
  57. Dern K, van Eps A, Wittum T, Watts M, Pollitt C, Belknap J. Effect of Continuous Digital Hypothermia on Lamellar Inflammatory Signaling When Applied at a Clinically-Relevant Timepoint in the Oligofructose Laminitis Model.. J Vet Intern Med 2018 Jan;32(1):450-458.
    doi: 10.1111/jvim.15027pmc: PMC5787192pubmed: 29282770google scholar: lookup
  58. Pollitt CC. Basement membrane pathology: a feature of acute equine laminitis.. Equine Vet J 1996 Jan;28(1):38-46.
    doi: 10.1111/j.2042-3306.1996.tb01588.xpubmed: 8565952google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,344 horse owners like you who receive our email updates on horse health and nutrition.